"p h Quest

"p h Quest vy Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 60 Gender: M Phone: 561.366.0084 Patient ID: 090443348 Health ID: 8573003290851249 Specimen Information Specimen: MR9529575 Requisition: 0012348 Collected: Received: Reported: 12/30/2013 12/31/2013 I 00:27 EST 01/02/2014 I 13:31 EST Test Name In Range Out Of Range HEPATITIS PANEL, ACUTE W/REFLEX TO CONFIRMATION HEPATITIS A IGM NON-REACTIVE HEPATITIS B SURFACE ANTIGEN W/REFL CONFIRM HEPATITIS B SURFACE ANTIGEN NON-REACTIVE HEPATITIS B CORE ANTIBODY (IGM) NON-REACTIVE HEPATITIS C ANTIBODY NON-REACTIVE SIGNAL TO CUT-OFF 0.02 LIPID PANEL CHOLESTEROL, TOTAL HDL CHOLESTEROL TRIGLYCERIDES LDL-CHOLESTEROL 217 H 28 L 474 H LDL cholesterol not calculated. Triglyceride levels greater than 400 mg/dL invalidate calculated LDL results. Desirable range <100 mg/dL for patients with CHD or diabetes and <70 mg/dL for diabetic patients with known heart disease. CHOL/HDLC RATIO 7.8 H NON HDL CHOLESTEROL 189 H Target for non-HDL cholesterol is 30 mg/dL higher than LDL cholesterol target. CARDIO CRP(R) 0.7 Lower relative cardiovascular risk according to AHA/CDC guidelines. For ages >17 cCRP mg/L <1.0 1.0-3.0 3.1-10.0 >10.0 Years: Risk According to AHA/CDC Guidelines Lower relative cardiovascular risk. Average relative cardiovascular risk. Higher relative cardiovascular risk. Consider retesting in 1 to 2 weeks to exclude a benign transient elevation in the baseline CRP value secondary to infection or inflammation. Persistent elevation, upon retesting, may be associated with infection and inflammation. HONOCYSTEINE, CARDIOVASCULAR COMPREHENSIVE METABOLIC PANEL GLUCOSE 16.6 H 114 H Client Information — Client #: 17436 56W5265 UCA/MOSKOWITZ BRUCE MD Attn: **P GR/UNIV.CLINICAL 1411 N FLAGLER DR STE 7100 WEST PALM BEACH, FL 33401 Reference Range NON-REACTIVE NON-REACTIVE NON-REACTIVE NON-REACTIVE <1.00 125-200 mg/dL > OR 40 mg/dL <150 mg/dL <130 mg/dL (talc) < OR = 5.0 (talc) mg/dL (talc) mg/L <11.4 umol/L 65-99 mg/dL Lab MI MI MI MI MI MI MI MI MI MI MI MI MI CLIENTSERVICES:866.697.8378 SPECIMEN: MR9529575 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGEI0F5 EFTA00316579 ain Quest eP r Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 60 Gender: M Patient ID: 090443348 Health ID: 8573003290851249 Specimen Information Specimen: Collected: Received: Reported: MR9529575 12/30/2013 12/31/2013 /00:27 EST 01/02/2014 13:31 EST Client Information Client #: 17436 Test Name In Range Out Of Range Reference Range Fasting reference interval UREA NITROGEN (BUN) 19 7-25 mg/dL CREATININE 0.94 0.70-1.25 mg/dL For patients >49 years of age, the reference limit for Creatinine is approximately 13% higher for people identified as African-American. eGFR NON-AFR. AMERICAN eGFR AFRICAN AMERICAN BUN/CREATININE RATIO SODIUM POTASSIUM 4.6 Results slightly increased due to hemolysis. 88 102 NOT APPLICABLE 140 CHLORIDE CARBON DIOXIDE CALCIUM PROTEIN, TOTAL ALBUMIN GLOBULIN ALBUMIN/GLOBULIN RATIO BILIRUBIN, TOTAL ALKALINE PHOSPHATASE AST ALT URIC ACID Therapeutic target 106 23 9.8 6.9 4.2 2.7 1.6 0.9 58 19 23 7.1 for gout patients: <6.0 mg/dL PROTEIN, TOTAL AND PROTEIN ELECTROPHORESIS PROTEIN, TOTAL, SERUM PROTEIN, TOTAL 6.9 PROTEIN ELECTROPHORESIS ALBUMIN 3.9 ALPHA-1-GLOBULINS 0.2 ALPHA-2-GLOBULINS 0.9 BETA GLOBULINS 0.9 GAMMA GLOBULINS 1.0 INTERPRETATION Protein electrophoresis pattern appears normal. LD TSH T4 (THYROXINE), TOTAL FREE T4 INDEX (T7) T3 UPTAKE SED RATE BY MODIFIED WESTERGREN URINALYSIS, COMPLETE Soo Endnote 2 CBC (INCLUDES DIFF/PLT) WHITE BLOOD CELL COUNT RED BLOOD CELL COUNT HEMOGLOBIN 182 1.12 7.6 2.4 31 2 > OR = 60 mL/min/1.73m2 > OR = 60 mL/min/1.73m2 6-22 (calc) 135-146 mmol/L 3.5-5.3 mmoi/L 98-110 mmol/L 19-30 mmol/L 8.6-10.3 mg/dL 6.1-8.1 g/dL 3.6-5.1 g/dL 1.9-3.7 g/dL (calc) 1.0-2.5 (calc) 0.2-1.2 mg/dL 40-115 U/L 10-35 U/L 9-46 U/L 4.0-8.0 mg/dL 6.1-8.1 g/dL 3.5-4.7 g/dL 0.1-0.3 g/dL 0.5-1.0 g/dL 0.8-1.4 g/dL 0.6-1.6 g/dL 120-250 U/L 0.40-4.50 mIU/L 4.5-12.0 mcg/dL 1.4-3.8 22-35 % < OR = 20 mm/h 3.9 3.8-10.8 Thousand/uL 5.02 4.20-5.80 Million/uL 14.8 13.2-17.1 g/dL Lab MI MI MI MI MI MI MI MI MI CLIENn'SERIMES:866.6971378 SPECIMEN: MR9529575 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 2 OF 5 EFTA00316580 Aopia (1est eP r Diagnostics Report Status: Partial EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 60 Gender: M Patient ID: 090443348 Health ID: 8573003290851249 Specimen Information Specimen: Collected: Received: Reported: MR9529575 12/30/2013 12/31/2013 /00:27 EST 01/02/2014 13:31 EST Client Information Client #: 17436 Test Name In Range Out Of Range HEMATOCRIT 43.7 MCV 86.9 MCH 29.5 MCHC 33.9 RDW 13.5 PLATELET COUNT 241 DIFFERENTIAL, MANUAL ABSOLUTE NEUTROPHILS 936 L ABSOLUTE LYMPHOCYTES 2340 ABSOLUTE MONOCYTES 195 L ABSOLUTE EOSINOPHILS 390 ABSOLUTE BASOPHILS 39 NEUTROPHILS 24 LYMPHOCYTES 60 MONOCYTES EOSINOPHILS 10 BASOPHILS 1 CBC MORPHOLOGY Review of peripheral automated results. Although an "automated CBC" was ordered, our instrumentation detected an abnormality on your patient's specimen requiring us to perform a manual review. VITAMIN B12 Reference Range 38.5-50.0 % 80.0-100.0 fL 27.0-33.0 pg 32.0-36.0 g/dL 11.0-15.0 % 140-400 Thousand/uL 1500-7800 cells/uL 850-3900 cells/uL 200-950 cells/uL 15-500 cells/uL 0-200 cells/uL NORMAL smear confirms 369 200-1100 pg/mL Please Note: Although the reference range for vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1₹ of patients with values above 400 pg/mL will have symptoms. C-REACTIVE PROTEIN <0.10 <0.80 mg/dL Please be advised that patients taking Carboxypenicillins may exhibit falsely decreased C-Reactive Protein levels due to an analytical interference in this assay. CORTISOL, TOTAL 9.3 mcg/dL Reference Range: For 8 a.m.(7-9 a.m.) Specimen: 4.0-22.0 Reference Range: For 4 III.(3-5 p.m.) Specimen: 3.0-17.0 * Please interpret above results accordingly * TESTOSTERONE, TOTAL, MALES 163 L Reference Range Adult 241-827 Aging men with clinically significant hypogonadal symptoms and testosterone values repeatedly in the range of 200-300 ng/dL or less, may benefit from testosterone treatment after adequate risk and benefits counseling. In hypogonadal males, Testosterone, Total, LC/MS/MS, is the recommended assay. This test code (15983) must be collected in a red-top tube with no gel. The ng/dL Lab MI MI MI MI MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 Quest. Quest Diagnostics. the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE30F5 EFTA00316581 an Quest Diagnostics, Report Status: Partial EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 60 Gender: M Patient ID: 090443348 Health ID: 8573003290851249 Specimen Information Specimen: Collected: Received: Reported: MR9529575 12/30/2013 12/31/2013 / 00:27 EST 01/02/2014 / 13:31 EST Client Information Client #: 17436 Test Name In Range Endocrine Society recommends obtaining at least two morning (8-10 a.m.) samples on different days when screening for hypogonadism. PSA, TOTAL 0.5 Endnote I This test was performed using the Siemens chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. * Test not performed. * No urine received. Out Of Range Reference Range < OR = 4.0 ng/mL Lab MI CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 4 OF 5 EFTA00316582 gsisk Quest a , Diagnostic, Report Status: Partial EPSTEIN, JEFFREY Patient Information EPSTEIN, JEFFREY DOB: 01/20/1953 AGE: 60 Gender: M Patient ID: 090443348 Health ID: 8573003290851249 Specimen Information Specimen: Collected: Received: Reported: MR9529575 12/30/2013 12/31/2013 /00:27 EST 01/02/2014 13:31 EST Client Information Client #: 17436 RHEUMATOID ARTHRITIS REPORT ANA IFA SCREEN W/REFL TO TITER AND PATTERN, IFA Test Name Results Reference Range ANA SCREEN. IFA NEGATIVE NEGATIVE Lab: MI PENDING TESTS: VITAMIN D. 25-HYDROXY. LOMS/MS LYME DISEASE ANTIBODIES (IGG.IGM). IMMUNOBLOT IMMUNOFIXATION. SERUM HIV At HIV If2. EIA, WITH REFLEXES PERFORMING SITE: MI QUEST DIAGNOSTICS.MIAMI. 10200 COMMERCE PARKWAY. MIRAMAR. FL 33025.3938 Laboraimy Director: GLEN L HORTIN MD PHD. CL1A: I 0D027733.1 CLIENT SERVICES: 866.697.8378 SPECIMEN: MR9529575 Quest. Quest Diagnostics, the associated logo and all associated Quest Diagnostics marks are the trademarks of Quest Diagnostics. PAGE 5 OF 5 EFTA00316583